Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses

Vaccine

Volumn 27, Issue 23, 2009, Pages 3083-3089

  Patel, Ami ^a,b   Tran, Kaylie ^a   Gray, Michael ^a   Li, Yan ^a   Ao, Zhujun ^b   Yao, Xiaojian ^b   Kobasa, Darwyn ^a,b   Kobinger, Gary P ^a,b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Avian influenza; Cell mediated immunity; DNA vaccine; H5N1

Indexed keywords

DNA VACCINE; HEMAGGLUTININ; ION CHANNEL; NEUTRALIZING ANTIBODY; NUCLEOPROTEIN; SIALIDASE; VIRUS ANTIGEN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; HEMAGGLUTINATION INHIBITION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; ANTIGENS, VIRAL; CELL LINE; CONSERVED SEQUENCE; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; LYMPHOCYTE ACTIVATION; MACACA FASCICULARIS; MALE; MICE; MICE, INBRED BALB C; NEURAMINIDASE; NUCLEOPROTEINS; VACCINATION; VACCINES, DNA; VIRAL MATRIX PROTEINS;

EID: 67349094613     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.023     Document Type: Article

References (34)

1. Chen H., Smith G.J., Li K.S., Wang J., Fan X.H., Rayner J.M., et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci USA 103 February (8) (2006) 2845-2850
2. Jiang Y., Yu K., Zhang H., Zhang P., Li C., Tian G., et al. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Antivir Res 75 September (3) (2007) 234-241
3. Kilpatrick A.M., Chmura A.A., Gibbons D.W., Fleischer R.C., Marra P.P., and Daszak P. Predicting the global spread of H5N1 avian influenza. Proc Natl Acad Sci USA 103 December (51) (2006) 19368-19373
4. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., and Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 56 March (1) (1992) 152-179
5. WHO. WHO | Avian Influenza. 2008 [cited 2008 09.03.08]. Available from: http://www.who.int/csr/disease/avian_influenza/en/.
6. Taubenberger J.K., Reid A.H., Lourens R.M., Wang R., Jin G., and Fanning T.G. Characterization of the 1918 influenza virus polymerase genes. Nature 437 October (7060) (2005) 889-893
7. Tumpey T.M., Basler C.F., Aguilar P.V., Zeng H., Solorzano A., Swayne D.E., et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310 October (5745) (2005) 77-80
8. Johnson N.P., and Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 76 Spring (1) (2002) 105-115
9. Palese P. Making better influenza virus vaccines?. Emerg Infect Dis 12 January (1) (2006) 61-65
10. WHO. World Health Organization Recommendations for Influenza Vaccines 2008 [cited 2008 03.08.08]. Available from: http://www.who.int/csr/disease/influenza/vaccinerecommendations/en/index.html.
11. Bergen R., Black S., Shinefield H., Lewis E., Ray P., Hansen J., et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 23 February (2) (2004) 138-144
12. Treanor J.J., Campbell J.D., Zangwill K.M., Rowe T., and Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354 March (13) (2006) 1343-1351
13. Laddy D.J., and Weiner D.B. From plasmids to protection: a review of DNA vaccines against infectious diseases. Int Rev Immunol 25 May-August (3-4) (2006) 99-123
14. Laddy D.J., Yan J., Corbitt N., Kobasa D., Kobinger G.P., and Weiner D.B. Immunogenicity of novel consensus-based DNA vaccines against avian influenza. Vaccine 25 April (16) (2007) 2984-2989
15. Ramakrishna L., Anand K.K., Mohankumar K.M., and Ranga U. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization. J Virol 78 September (17) (2004) 9174-9189
16. Sharp P.M., Cowe E., Higgins D.G., Shields D.C., Wolfe K.H., and Wright F. Codon usage patterns in Escherichia coli, Bacillus subtilis, Saccharomyces cerevisiae, Schizosaccharomyces pombe. Drosophila melanogaster and Homo sapiens: a review of the considerable within-species diversity. Nucleic Acids Res 16 September (17) (1988) 8207-8211
17. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 37 April (4) (1999) 937-943
18. Ulmer J.B., Fu T.M., Deck R.R., Friedman A., Guan L., DeWitt C., et al. Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J Virol 72 July (7) (1998) 5648-5653
19. Kodihalli S., Kobasa D.L., and Webster R.G. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines. Vaccine 18 May (23) (2000) 2592-2599
20. Epstein S.L., Kong W.P., Misplon J.A., Lo C.Y., Tumpey T.M., Xu L., et al. Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Vaccine 23 November (46-47) (2005) 5404-5410
21. Ao Z., Patel A., Tran K., He X., Fowke K., Coombs K., et al. Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules. Antiviral Res 79 July (1) (2008) 12-18
22. Kobinger G.P., Feldmann H., Zhi Y., Schumer G., Gao G., Feldmann F., et al. Chimpanzee adenovirus vaccine protects against Zaire Ebola virus. Virology 346 March (2) (2006) 394-401
23. Kodihalli S., Goto H., Kobasa D.L., Krauss S., Kawaoka Y., and Webster R.G. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J Virol 73 March (3) (1999) 2094-2098
24. Patel A., Zhang Y., Croyle M., Tran K., Gray M., Strong J., et al. Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice. J Infect Dis 196 November (Suppl. 2) (2007) S413-S420
25. Rao S., Kong W.-P., Wei C.-J., Yang Z.-Y., Nason M., Styles D., et al. Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice. PLoS ONE 3 6 (2008) e2432
26. Horimoto T., and Kawaoka Y. Strategies for developing vaccines against H5N1 influenza A viruses. Trends Mol Med 12 November (11) (2006) 506-514
27. Subbarao K., and Luke C. H5N1 viruses and vaccines. PLoS Pathog 3 March (3) (2007) e40
28. Lipatov A.S., Hoffmann E., Salomon R., Yen H.L., and Webster R.G. Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets. J Infect Dis 194 October (8) (2006) 1040-1043
29. Fu T.M., Friedman A., Ulmer J.B., Liu M.A., and Donnelly J.J. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J Virol 71 April (4) (1997) 2715-2721
30. Rimmelzwaan G.F., Fouchier R.A., and Osterhaus A.D. Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. Curr Opin Biotechnol 18 December (6) (2007) 529-536
31. Gao W., Soloff A.C., Lu X., Montecalvo A., Nguyen D.C., Matsuoka Y., et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 80 February (4) (2006) 1959-1964
32. Epstein S.L., Tumpey T.M., Misplon J.A., Lo C.Y., Cooper L.A., Subbarao K., et al. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerg Infect Dis 8 August (8) (2002) 796-801
33. Laddy D.J., Yan J., Kutzler M., Kobasa D., Kobinger G.P., Khan A.S., et al. Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. PLoS ONE 3 6 (2008) e2517
34. Hoelscher M.A., Singh N., Garg S., Jayashankar L., Veguilla V., Pandey A., et al. A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. J Infect Dis 197 April (8) (2008) 1185-1188